This is a demo store. No orders will be fulfilled.

Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 20 Dec 2017  |  North America

    Strategic Insight into the Global Women’s Healthcare Market, 2017

    Opportunities in Point-of-care (POC) Diagnostics for Cardiology and Oncology, along with Wearables, Stand out in the Market

    Across the world, women typically live longer than men. The reason behind the difference between male and female life expectancy is unclear but could be explained through biological, environmental, and behavioral factors. Because women typically outlive men, they are more likely to suffer from ill health and other age-related diseases. Women’s he...

    $1,500.00
  2. 12 Dec 2017  |  North America

    Growth Insights—Global Pharmaceutical Drug Discovery IT Solutions Market, Forecast to 2020

    Digitalization in Drug Discovery Presents Significant Growth Opportunities for Healthcare IT Companies

    The growing focus of pharmaceutical companies on reducing their drug discovery spending has resulted in companies looking to adopt information technology and informatics solutions to achieve efficiency in their R&D operations. While adoption of IT solutions in clinical research and trial activities is relatively high, drug discovery digital solutio...

    $1,500.00
  3. 07 Nov 2017  |  North America

    Growth Insights on the US Therapeutic Apheresis Market, Forecast to 2021

    Product Diversification, Focus on Therapeutic Plasmapheresis and Pathogen-Reduced Platelets Will Be Key to Success

    The study covers current and future market trends, drivers, challenges, and opportunities in US therapeutic apheresis market. It breaks down the market into hematology and oncology, neurology, rheumatology, and other therapeutic areas. Therapeutic apheresis has become an essential element of the blood and blood components industry value chain. Hosp...

    $1,500.00
  4. 06 Nov 2017  |  South Asia, Middle East & North Africa

    Growth and Investment Opportunities in Nepal Healthcare Market, 2017

    Incidence of Non-Communicable Diseases increasing leading to demand for specialty services

    This industry docket assess Nepal's healthcare market and highlights investment opportunities therein. The country lacks centers of excellence in tertiary care leading to outflow of patients seeking the same. Nepal is currently seeing increasing investment by private and corporate hospital sectors in speciality services like Cardiac Sciences, Neu...

    $1,500.00
  5. 31 Oct 2017  |  Global

    Global Digital Pathology Market, 2017 Companies-To-Action

    Collaborative Business Models Embracing Artificial Intelligence Application in Novel Disease Areas to Drive Market Growth

    It is estimated that more than 19,000 pathologists would be needed to serve the US healthcare needs. However, the actual number is expected to be approximately 40% lesser. Similar trends are foreseen globally driven by aging population and widening application in areas such as cancer diagnostics, drug development, clinical trials, biomarker discove...

    $3,000.00
  6. 31 Oct 2017  |  North America

    Growth Insights on the Global CRISPR/Cas9 Tools Market, 2017

    A Disruptive Technology—Gene-editing Tools for Multiple Applied Industries

    Since its inception, CRISPR has gained strong traction from the global research community because of its huge potential in diverse applications. Considering CRISPR’s disruptive and game-changing applications, a number of large and small participants have invested in this domain. Along the same line, CRISPR has witnessed a multi-fold uptake in fun...

    $3,000.00
  7. 17 Jul 2017  |  North America

    US Oncology Diagnostics Market, Forecast to 2021

    Manufacturers Increase Assay Development Focus Toward Screening, Prevention, and Therapy Selection

    Personalized medicine continues to be a driver of new diagnostics to characterize the properties of an individual’s cancer. As a result, there is an increased focus on the development of non-invasive liquid biopsy companion diagnostic tests that would aid in choosing the best treatment for an individual. Liquid biopsy has triggered market consoli...

    $4,950.00
  8. 23 Jun 2017  |  Europe

    Growth Opportunities in the Western European IVD Industry, Forecast to 2021

    Increased R&D Investments and M&As Propel the Growth of Mobile POCT and Clinical Genomics Solutions

    Despite global economic and industry challenges, in-vitro diagnostics (IVD) markets continue to grow, mainly due to fast-growing segments like molecular diagnostics, point-of-care testing (POCT), and tissue diagnostics.. A few market dynamics are either positively or negatively affecting certain specific segments in the IVD space; for example, the ...

    $4,950.00
  9. 22 Jun 2017  |  Asia Pacific

    Malaysia, Singapore, and Indonesia Transformational Health Insights, 2017–2022

    Rapid Growth, Reforms, and Partnerships are Transforming Healthcare Systems in Malaysia, Singapore, and Indonesia

    Southeast Asia (SEA) is emerging as the gold mine for both local and international healthcare vendors. Within SEA, Malaysia, Singapore, and Indonesia still have unexplored and under-served markets providing boundless opportunities for healthcare vendors with innovative products and services. To be able to capitalize on the market, medical device ma...

    $1,500.00
  10. 20 Jun 2017  |  North America

    Transformation and Growth Opportunities in the US Next-Generation Sequencing Informatics Market

    Pharmaceutical and Molecular Diagnostics Segments to Lead Revenue Growth

    Frost & Sullivan expects strong demand for commercial application-focused solutions to drive new investments in the development of tools and technologies, and will also result in consolidation of the US next-generation sequencing informatics market. Changing customer requirements and intense competition will drive the transformation. As companies l...

    $4,950.00